Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway
Ali Masjedi(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Afshin Namdar(University of Alberta), Afshin Nikkhoo(Tabriz University of Medical Sciences), Ali Rastegari(Tehran University of Medical Sciences), Abbas Mirshafiey(University of Mazandaran), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Hassan Soleimanpour(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Ghasem Ghalamfarsa(Yasuj University of Medical Sciences), Hadi Hassannia(Mazandaran University of Medical Sciences), Fatemeh Atyabi(Tehran University of Medical Sciences)
Cited by 81
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312